Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SLEEP: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | SLEEP |
| Key Genes/Proteins | ALZHEIMER DISEASE |
Knowledge base pages for this entity
graph TD
SLEEP["SLEEP"]
SLEEP -->|"activates"| Glymphatic_Pathway["Glymphatic Pathway"]
SLEEP -->|"modulates"| CIRCADIAN_RHYTHM["CIRCADIAN RHYTHM"]
SLEEP -->|"modulates"| Circadian_Rhythm["Circadian Rhythm"]
SLEEP -->|"contributes to"| Healthy_Brain_Aging["Healthy Brain Aging"]
SLEEP -->|"regulates"| HSPA1A["HSPA1A"]
GABAergic_Interneurons["GABAergic Interneurons"] -->|"regulates"| SLEEP
Circadian_Clocks["Circadian Clocks"] -->|"regulates"| SLEEP
Caffeine["Caffeine"] -->|"modulates"| SLEEP
Serotonin["Serotonin"] -->|"regulates"| SLEEP
HSPA1A -->|"regulates"| SLEEP
ADENOSINE_RECEPTORS["ADENOSINE RECEPTORS"] -->|"regulates"| SLEEP
n_5_HT["5-HT"] -->|"modulates"| SLEEP
MTNR1B["MTNR1B"] -->|"regulates"| SLEEP| Target | Relation | Type | Str |
|---|---|---|---|
| interstitial space | associated_with | process | 0.95 |
| β-amyloid | associated_with | protein | 0.95 |
| Metabolite Clearance | promotes | process | 0.95 |
| glymphatic_clearance | activates | mechanism | 0.95 |
| Glymphatic Pathway | activates | pathway | 0.92 |
| Waste Product Removal | promotes | process | 0.92 |
| Glymphatic Transport | regulates | process | 0.90 |
| Metabolic Homeostasis | involved_in | process | 0.90 |
| glymphatic system activity | activates | process | 0.90 |
| CIRCADIAN RHYTHM | modulates | entity | 0.90 |
| neurotoxic waste products | associated_with | compound | 0.90 |
| central nervous system | associated_with | brain_region | 0.90 |
| cerebrospinal fluid | modulates | compound | 0.90 |
| Interstitial Space | modulates | phenotype | 0.85 |
| APOE | associated_with | protein | 0.85 |
| Brain_Homeostasis | associated_with | process | 0.85 |
| Circadian Rhythm | modulates | process | 0.85 |
| cellular repair mechanisms | mediates | process | 0.85 |
| Brain Homeostasis | associated_with | process | 0.85 |
| Healthy Brain Aging | contributes_to | phenotype | 0.80 |
| Cognitive Function | contributes_to | phenotype | 0.80 |
| Neurodegeneration | associated_with | disease | 0.80 |
| Healthy_Brain_Aging | promotes | phenotype | 0.80 |
| Neurodegeneration_Processes | modulates | process | 0.80 |
| Cognition | correlates_with | phenotype | 0.75 |
| Cancer | associated_with | disease | 0.75 |
| HSPA1A | regulates | protein | 0.75 |
| Alzheimer Disease | biomarker_for | disease | 0.75 |
| glymphatic clearance | activates | process | 0.70 |
| Cognitive Function | regulates | phenotype | 0.70 |
| GLYMPHATIC CLEARANCE | regulates | phenotype | 0.70 |
| WHITE MATTER | co_discussed | entity | 0.50 |
| TLR4 | co_discussed | entity | 0.50 |
| TNF | co_discussed | entity | 0.50 |
| SOD1 | co_discussed | entity | 0.50 |
| TBI | co_discussed | entity | 0.50 |
| THALAMUS | co_discussed | entity | 0.50 |
| T CELLS | co_discussed | entity | 0.50 |
| TAU | co_discussed | entity | 0.50 |
| TDP-43 | co_discussed | entity | 0.50 |
| SYNAPTIC PLASTICITY | co_discussed | entity | 0.50 |
| T CELL | co_discussed | entity | 0.50 |
| UNFOLDED PROTEIN RESPONSE | co_discussed | entity | 0.50 |
| SYNAPSE | co_discussed | entity | 0.50 |
| STING | co_discussed | entity | 0.50 |
| MICROGLIA | causes | entity | 0.50 |
| STROKE | co_discussed | entity | 0.50 |
| TREM2 | co_discussed | entity | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| 33268891 | needed for | paper | 0.90 |
| 33268891 | promote | paper | 0.90 |
| Serotonin | regulates | compound | 0.90 |
| GABAergic Interneurons | regulates | cell_type | 0.90 |
| 34902819 | influences | paper | 0.90 |
| 41579208 | regulates | paper | 0.90 |
| Caffeine | modulates | compound | 0.90 |
| 28514446 | induces | paper | 0.90 |
| Circadian Clocks | regulates | process | 0.90 |
| Hsp70 | associated_with | protein | 0.85 |
| ADENOSINE RECEPTORS | regulates | receptor | 0.85 |
| HSPA1A | regulates | gene | 0.85 |
| Brain Function | associated_with | process | 0.80 |
| 5-HT | modulates | compound | 0.75 |
| Alzheimer's Disease | modulates | disease | 0.70 |
| melatonin receptor 2 | regulates | gene | 0.70 |
| 34902819 | associated with | paper | 0.60 |
| 40830882 | reduces | paper | 0.60 |
| 40830882 | increases | paper | 0.60 |
| HSPA1A | associated_with | gene | 0.60 |
| MTNR1B | regulates | gene | 0.60 |
| ALZHEIMER DISEASE | associated_with | gene | 0.60 |
| 25947369 | enables elimination of | paper | 0.60 |
| AMYGDALA | co_discussed | entity | 0.50 |
| CHOLINERGIC | co_discussed | entity | 0.50 |
| P2RX7 | co_discussed | entity | 0.50 |
| BRAINSTEM | co_discussed | entity | 0.50 |
| GBA | co_discussed | entity | 0.50 |
| SENESCENCE | co_discussed | entity | 0.50 |
| AXON | co_discussed | entity | 0.50 |
| AKT | co_discussed | entity | 0.50 |
| MTOR | co_discussed | entity | 0.50 |
| HUNTINGTON | co_discussed | entity | 0.50 |
| LRRK2 | co_discussed | entity | 0.50 |
| MONOCYTE | co_discussed | entity | 0.50 |
| MONOCYTES | co_discussed | entity | 0.50 |
| APOE | co_discussed | entity | 0.50 |
| AQP4 | co_discussed | entity | 0.50 |
| ASTROCYTE | co_discussed | entity | 0.50 |
| NEURON | co_discussed | entity | 0.50 |
| PARKINSON | co_discussed | entity | 0.50 |
| PARKINSON'S | co_discussed | entity | 0.50 |
| DEPRESSION | co_discussed | entity | 0.50 |
| EPILEPSY | co_discussed | entity | 0.50 |
| DOPAMINERGIC | co_discussed | entity | 0.50 |
| GABA | co_discussed | entity | 0.50 |
| GABAergic | co_discussed | entity | 0.50 |
| NEUROINFLAMMATION | co_discussed | entity | 0.50 |
| OXIDATIVE STRESS | co_discussed | entity | 0.50 |
| MICROGLIA | co_discussed | entity | 0.50 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.735
neurodegeneration | 2026-04-01 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Phenobarbital treatment efficacy study | clinical | intractable epilepsy | 0.900 | 0.00 | human patient and Gabra1+/-/Ga | proposed | N/A |
| Gabra1+/-/Gabrg2+/- mouse model characterization | validation | epilepsy with optic atrophy | 0.900 | 0.00 | Gabra1+/-/Gabrg2+/- mice | proposed | N/A |
| Optic nerve myelination analysis | exploratory | optic atrophy | 0.880 | 0.00 | Gabra1+/-/Gabrg2+/- mice | proposed | N/A |
| GABAA receptor subunit expression analysis | exploratory | epilepsy | 0.850 | 0.00 | Gabra1+/-/Gabrg2+/- mice | proposed | N/A |
| Brain Connectivity-Targeted tACS Trial in Early AD | clinical | Alzheimer's Disease | 0.509 | 0.50 | human postmortem brain tissue | proposed | $520,000 |
| s:** - Test whether HCN1 knockout specifically in EC layer II accelera | falsification | Alzheimer's Disease | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| tACS Connectivity Trial in Early Alzheimer's | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Brain Connectivity-Targeted tACS Trial in Early AD | clinical | Alzheimer's Disease | 0.400 | 0.50 | mouse | proposed | $730,000 |
| DLB Cognitive Fluctuation Mechanism Experiment | clinical | Neurodegeneration | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Migraine Cortical Hyperexcitability and Alzheimer's Disease Risk: Long | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Neural Oscillation Dysfunction Validation in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Non-Motor Symptom Progression in Parkinson's Disease — Mechanisms and | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Sleep and Circadian Dysfunction as Driver of Neurodegeneration | clinical | Neurodegeneration | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Sleep Disruption and Alzheimer's Disease — mechanism and intervention | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
| Proposed experiment from debate on Astrocytes adopt A1 (neurotoxic) an | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $80,000 |
| Non-Dopaminergic Neurotransmitter Degeneration in PD - Experiment Desi | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| A brain-to-gut signal controls intestinal fat absorption. [PMID:39261733] | Lyu Q, Xue W, Liu R, Ma Q, Kasaragod VB, | Nature | 2024 | 1 |
| Epilepsy plus blindness in microdeletion of GABRA1 and GABRG2 in mouse and human [PMID:37703949] | Zhang Q, Forster-Gibson C, Bercovici E, | Exp Neurol | 2023 | 1 |
| Pharmacogenetics of anxiety and depression in Alzheimer's disease. [PMID:36628952] | Cacabelos R, Carril JC, Corzo L, Pego R, | Pharmacogenomics | 2023 | 1 |
| Genetic factors in precocious puberty. [PMID:34665958] | Shim YS, Lee HS, Hwang JS | Clin Exp Pediatr | 2022 | 1 |
| Sleep drives metabolite clearance from the adult brain. [PMID:24136970] | Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Th | Science | 2013 | 1 |
| Effects of caffeine on sleep and cognition. [PMID:21531247] | Snel J, Lorist MM | Prog Brain Res | 2011 | 1 |
| Functional dissection of Timekeeper (Tik) implicates opposite roles for CK2 and [PMID:19536808] | Kunttas-Tatli E, Bose A, Kahali B, Bisho | Genesis | 2009 | 1 |
| CI-994 is a dual modulator of class I HDACs and Wnt/β-catenin signaling for the [PMID:41654970] | Lu W, Kawatani K, Ren Y | Alzheimers Res Ther | 2026 | 0 |
| Molecular brake on firing pattern transitions in MHbChAT neurons to mediate nico [PMID:41903536] | Zheng ZW, Min PX, Luo YL, Mao XF, Zhang | Neuron | 2026 | 0 |
| Estradiol modulates neuronal network hyperexcitability in select NDD risk genes. [PMID:41757108] | Pruitt A, Yang L, Lee S, Balafkan N, Sea | bioRxiv : the preprint server | 2026 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Prenatal alcohol exposure dysregulates the expression of clock genes and alters [PMID:41086861] | Reina-Campos M, Gallego-Landin I, Medran | Open biology | 2025 | 0 |
| Sleep-improving effect and the potential mechanism of Morus alba L. on mice. [PMID:39255910] | Kong X, Zhou X, Li R, Kang Q, Hao L, Zhu | Fitoterapia | 2024 | 0 |
| Vitamin D supplementation and COVID-19 risk: a population-based, cohort study. [PMID:34273098] | ["Oristrell J", "Oliva J", "Casado E", " | Journal of endocrinological in | 2022 | 0 |
| Intracellular calcium homeostasis and its dysregulation underlying epileptic sei [PMID:36403388] | Zhou X, Chen Z, Xiao L, Zhong Y, Liu Y, | Seizure | 2022 | 0 |
| To beat Omicron, Delta and bird flu, Europe must pull together [PMID:34893768] | Desvars-Larrive Amélie | Nature | 2021 | 0 |
| Facilitating successful online meetings in healthcare. [PMID:33789331] | Dennis Sherrod; Cecil Holland | Nursing management | 2021 | 0 |
| Homeostatic plasticity and burst activity are mediated by hyperpolarization-acti [PMID:33547341] | Rátkai A, Tárnok K, Aouad HE, Micska B, | Scientific reports | 2021 | 0 |
| Machine learning reveals bilateral distribution of somatic L1 insertions in huma [PMID:33432196] | ["Zhu X", "Zhou B", "Pattni R", "Gleason | Nature neuroscience | 2021 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 1.00 · 2026-04-26
closed · Rounds: 4 · Score: 0.95 · 2026-04-01
Hypotheses and analyses mentioning SLEEP in their description or question text
Score: 0.545 · unknown disease · 2026-04-26
At doses of 50-100 mg, trazodone increases slow-wave sleep continuity and REM duration, indirectly enhancing glymphatic
Score: 0.500 · Alzheimer's disease · 2026-04-28
H4 represents the strongest systems-neuroscience endpoint from the debate, focusing on restoring hippocampal sleep physi
Score: 0.380 · synaptic biology · 2026-04-27
The circadian-regulated expression of complement regulators CD55 and CD46 on synaptic membranes establishes a temporal g